| Host: | HEK293 cells |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Formulation: | Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4. or Supplied as a 0.22 Mu m filtered solution in PBS, pH 7.4. |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method: | < 0.1 EU/Mu g of the protein by LAL method. |
| Immunoreactivity: | Measured by its binding ability in a functional ELISA. Immobilized Recombinant Human ACE2 Protein at 2 Mu g/mL (100 Mu L/well) can bind Recombinant SARS-COV-2 Spike RBD-mFc Protein, the EC50 of Recombinant SARS-COV-2 Spike RBD-mFc Protein |
| Immunogen Region: | Arg319-Phe541 |
| Immunogen: | Recombinant SARS-CoV-2 (2019-nCoV) Spike RBD Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Arg319-Phe541) of SARS-COV-2 (2019-nCoV) Spike RBD (Accession #YP_009724390.1) fused with a mFc tag at |
| Immunogen Sequence: | RVQPTESIVRFPNITNLCPF GEVFNATRFASVYAWNRKRI SNCVADYSVLYNSASFSTFK CYGVSPTKLNDLCFTNVYAD SFVIRGDEVRQIAPGQTGKI ADYNYKLPDDFTGCVIAWNS NNLDSKVGGNYNYLYRLFRK SNLKPFERDISTEIYQAGST PCNGVEGFNCYFPLQSYGFQ PTNGVGYQPYRVVVLSFELL HAPATVCGPKKSTNLVKNKC VNF |
| Background | Recombinant SARS-CoV-2 (2019-nCoV) Spike RBD Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Arg319-Phe541) of SARS-COV-2 (2019-nCoV) Spike RBD (Accession #YP_009724390.1) fused with a mFc tag at the C-terminus. |
Information sourced from Uniprot.org